Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide versus ethacrynic acid continuous infusion after pediatric cardiac surgery
2012-004343-80Phase 3Active
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing Continuous infusion furosemide with Continuous infusion ethacrynic acid (2 arms). Primary endpoint: Urine output at the end of postoperative day 1. Started Oct 2012; status: active.
02
Drugs
furosemideethacrynic acid
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2012-004343-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004343-80.